Janney Montgomery Scott LLC Regenxbio Inc. Transaction History
Janney Montgomery Scott LLC
- $35.8 Billion
- Q3 2024
A detailed history of Janney Montgomery Scott LLC transactions in Regenxbio Inc. stock. As of the latest transaction made, Janney Montgomery Scott LLC holds 10,725 shares of RGNX stock, worth $123,981. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,725
Previous 12,287
12.71%
Holding current value
$123,981
Previous $144,000
21.53%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding RGNX
# of Institutions
205Shares Held
43.4MCall Options Held
83.9KPut Options Held
83.4K-
Black Rock Inc. New York, NY8.61MShares$99.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.11MShares$59.1 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.57MShares$52.8 Million3.49% of portfolio
-
State Street Corp Boston, MA2.87MShares$33.2 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY2.48MShares$28.6 Million0.0% of portfolio
About REGENXBIO Inc.
- Ticker RGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,230,000
- Market Cap $500M
- Description
- REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...